Pier Giuseppe Pelicci, PhD, MD

Prof. Pier Giuseppe Pelicci is Director of Research and Chairman of the Department of Experimental Oncology of the European Institute of Oncology (IEO), in Milan. He is also full professor at the University of Milan, President of the European School of Molecular Medicine (SEMM), and since the beginning of 2024, he has been the vice president of Alleanza Contro il Cancro (ACC), a network of 28 cancer research hospitals promoted and coordinated by the Ministry of Health, engaged in the set-up of multicentric mechanism–based clinical trials With a medical degree, a specialty in Internal Medicine and a PhD in Molecular Biology, he devoted his life to research, in the field having major impact on today’s clinical approach of treating cancer patients, such as the identification/functional characterization of PML-RAR and mutated-NPM oncogenes and the definition of the molecular basis of the current standard targeted treatment More recently, he has been focusing on the biological and molecular characterization of normal and cancer stem cells, on the mechanisms of DNA damage, on relapse acquired chemoresistance in leukaemia, and obesity as cancer risk factor.